Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders

A Yadav, MR Betts, RG Collman - Journal of neurovirology, 2016 - Springer
Abstract HIV-1-associated neurocognitive disorder (HAND) remains a persistent problem
despite antiretroviral therapy (ART), largely a result of continued inflammation in the …

Failure of atorvastatin to modulate CSF HIV-1 infection: results of a pilot study

JC Probasco, SS Spudich, J Critchfield, E Lee, N Lollo… - Neurology, 2008 - AAN Enterprises
Background: HIV-1 infection of the CSF space is nearly universal in untreated systemic
infection, and correlates strongly with intrathecal and systemic immunoactivation and CSF …

Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21

S Elahi, RH Weiss, S Merani - Aids, 2016 - journals.lww.com
Objective: Antigen persistence due to HIV is a major source of inflammation and substantial
immune activation, both of which are linked to accelerated aging. This illustrates the need to …

[HTML][HTML] Brief report: no evidence for an association between statin use and lower biomarkers of HIV persistence or immune activation/inflammation during effective …

RJ Bedimo, H Mar, RJ Bosch, H Drechsler… - JAIDS Journal of …, 2019 - journals.lww.com
Background: Statins exert pleiotropic anti-inflammatory and immune-modulatory effects,
which might translate into antiviral activity. We evaluated whether reported current statin …

Classical monocyte transcriptomes reveal significant anti-inflammatory statin effect in women with chronic HIV

E Ehinger, Y Ghosheh, AB Pramod, J Lin… - Cardiovascular …, 2021 - academic.oup.com
Aims During virally suppressed chronic HIV infection, persistent inflammation contributes to
the development of cardiovascular disease (CVD), a major comorbidity in people living with …

[HTML][HTML] Statins Disrupt CCR5 and RANTES Expression Levels in CD4+ T Lymphocytes In Vitro and Preferentially Decrease Infection of R5 Versus X4 HIV-1

AA Nabatov, G Pollakis, T Linnemann, WA Paxton… - PloS one, 2007 - journals.plos.org
Background Statins have previously been shown to reduce the in vitro infection of human
immunodeficiency virus type 1 (HIV-1) through modulation of Rho GTPase activity and lipid …

Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders

DW Williams, M Veenstra, PJ Gaskill… - Current HIV …, 2014 - ingentaconnect.com
HIV infected people are living longer due to the success of combined antiretroviral therapy
(cART). However, greater than 40-70% of HIV infected individuals develop HIV associated …

The combination of interferon‐beta and HMG‐CoA reductase inhibition in multiple sclerosis: Enthusiasm lost too soon?

J Sellner, MS Weber, P Vollmar… - CNS neuroscience & …, 2010 - Wiley Online Library
Recent studies support the notion that statins, widely prescribed cholesterol‐lowering
agents, may target key elements in the immunological cascade leading to inflammation and …

Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis

X Peng, J Jin, S Giri, M Montes, D Sujkowski… - Journal of …, 2006 - Elsevier
This study characterized immunomodulatory targets of statins in humans and their potential
for treatment of relapsing remitting multiple sclerosis (RR MS). Statins inhibited the …

Effect of statin use on inflammation and immune activation biomarkers in HIV-infected persons on effective antiretroviral therapy

SK Hussain, A Golozar, DP Widney… - AIDS research and …, 2021 - liebertpub.com
Immune activation and inflammation are hallmarks of chronic HIV infection and are
etiologically linked to major causes of morbidity and mortality among HIV-infected persons …